Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

被引:200
作者
Franzese, O
Kennedy, PTF
Gehring, AJ
Gotto, J
Williams, R
Maini, MK
Bertoletti, A
机构
[1] UCL, Inst Hepatol, London WC1E 6HX, England
[2] Royal Free Hosp, Inst Hepatol, London WC1E 6HX, England
[3] Royal Free Hosp, Ctr Hepatol, London WC1E 6HX, England
[4] UCL, Windeyer Inst Med Sci, Div Infect & Immun, London WC1E 6HX, England
[5] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy
关键词
D O I
10.1128/JVI.79.6.3322-3328.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD4(+) CD25(+) regulatory T cells have been shown to maintain peripheral tolerance against self and foreign antigens. In this study we analyzed the effect of circulating CD4(+) CD25(+) T cells on CD8(+)-T-cell responses of patients with chronic and resolved hepatitis B virus (HBV) infection. We demonstrated that circulating CD4+ CD25(+) T cells modulate the function and expansion of HBV-specific CD8(+) cells ex vivo in all patients, regardless of whether they have chronic or resolved HBV infection. The possible role of CD4(+) CD25(+) T cells in the pathogenesis of chronic HBV infection is not supported by these data. However, these results might have implications for optimizing future immunotherapeutic approaches to HBV treatment.
引用
收藏
页码:3322 / 3328
页数:7
相关论文
共 28 条
  • [1] Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens
    Aandahl, EM
    Michaëlsson, J
    Moretto, WJ
    Hecht, FA
    Nixon, DF
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (05) : 2454 - 2459
  • [2] Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420515, 10.1172/JCI200420415]
  • [3] Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
    Asano, M
    Toda, M
    Sakaguchi, N
    Sakaguchi, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 387 - 396
  • [4] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [5] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [6] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [7] Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
    Bertoletti, A
    Maini, MK
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) : 403 - 408
  • [8] Natural versus adaptive regulatory T cells
    Bluestone, JA
    Abbas, AK
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) : 253 - 257
  • [9] Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
    Boni, C
    Penna, A
    Ogg, GS
    Bertoletti, A
    Pilli, M
    Cavallo, C
    Cavalli, A
    Urbani, S
    Boehme, R
    Panebianco, R
    Fiaccadori, F
    Ferrari, C
    [J]. HEPATOLOGY, 2001, 33 (04) : 963 - 971
  • [10] Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation
    Câmara, NOS
    Sebille, F
    Lechler, RI
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) : 3473 - 3483